Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
US7419957B2 · kind B2 · utility
3Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2002 |
| Grant date | Sep 2, 2008 |
| Priority date | — |
| Expiry date | Jan 23, 2024 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5743
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100, bioassays using the peptides to diagnose, assess or prognose a mammal afflicted with cancer, more specifically melanoma or metastatic melanoma, and use of the proteins and peptides as immunogens to inhibit, prevent or treat melanoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.